Search Within

Govindaswami Ragupathi

Formats
  1. Journal Article (89)
  2. Meeting Abstract (50)
  3. Book Section (5)
Groups
  1. Department of Medicine (144)
  2. Melanoma Disease Management Team (144)
  3. Melanoma and Immunotherapeutics Service (144)
  4. Solid Tumor Oncology Division (144)
  5. Sloan Kettering Institute Faculty (56)
  6. Molecular Pharmacology and Chemistry Program Faculty (51)

More Groups

People
  1. Philip Livingston (118)
  2. Samuel Danishefsky (44)
  3. Kenneth Lloyd (17)
  4. Maria Spassova (17)
  5. Howard Scher (16)
  6. Susan Slovin (15)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (2)
  6. 2017 (1)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (24)
  2. Cancer Research (20)
  3. Cancer Immunology, Immunotherapy (15)
  4. Clinical Cancer Research (13)
  5. Journal of the American Chemical Society (8)
  6. Vaccine (7)

More Publications

Publishers
  1. American Association for Cancer Research (57)
  2. Springer (20)
  3. American Chemical Society (14)
  4. Elsevier Inc. (9)
  5. John Wiley & Sons (4)
  6. National Academy of Sciences (4)

More Publishers

Results (144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Journal Article

    Kahn, R. M.; Ragupathi, G.; Zhou, Q. C.; Iasonos, A.; Kravetz, S.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Aghajanian, C.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Phase I trial of oral yeast-derived β-glucan to enhance anti-GD2 immunotherapy of resistant high-risk neuroblastoma
    Journal Article

    Iglesias Cardenas, F.; Mauguen, A.; Cheung, I. Y.; Kramer, K.; Kushner, B. H.; Ragupathi, G.; Cheung, N. K. V.; Modak, S.
    Cancers (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Imaging patients with metastatic castration-resistant prostate cancer using (89)Zr-DFO-MSTP2109A anti-STEAP1 antibody
    Journal Article

    Carrasquillo, J. A.; Fine, B. M.; Pandit-Taskar, N.; Larson, S. M.; Fleming, S. E.; Fox, J. J.; Cheal, S. M.; O'Donoghue, J. A.; Ruan, S.; Ragupathi, G.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Pharmacokinetics and biodistribution of a [(86)Zr]Zr-DFO-MSTP2109A anti-STEAP1 antibody in metastatic castration-resistant prostate cancer patients
    Journal Article

    O'Donoghue, J. A.; Danila, D. C.; Pandit-Taskar, N.; Beylergil, V.; Cheal, S. M.; Fleming, S. E.; Fox, J. J.; Ruan, S.; Zanzonico, P. B.; Ragupathi, G.; more...
    Molecular Pharmaceutics (2019)

    Fulltext@MSK | Save